Azole Susceptibility and Resistance Mechanisms Surveys in Pathogenic Fungi by the CARST-fungi (2023-2024)

NCT06969703 · tracked via the Priya Life Science China tracker

Sponsor

Peking University First Hospital

Phase

Observational

Started

2025-06-10

Last updated

2025-05-14

Condition(s) studied

Fungal Disease

Study summary

The China Antifungal Resistance Surveillance Trial (CARST-fungi) study, which has been starting in July 2019, is a multi-center, prospective, observational, and laboratory-based study of pathogenic fungal isolates causing IFDs. All fungal isolates recovered from clinical samples will be collected. For each episode of fungal isolation, the information including the patient's age, gender, the ward location, the time of sample collection, and specimen type will be collected. All isolates will be sent to the Research Center for Medical Mycology, Beijing, China, for further study including species identification and azole susceptibility testing. Azole-resistant mechanisms will be elucidated by gene sequencing or expression level assay for resistance-related genes.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * fungal disease Exclusion Criteria: * non-fungal disease

Primary outcome measure(s)

The type and spectrum of azole-resistance in the pathogenic fungi — By the end of Dec. 2025

Trial sites (1)

Facility	City	Region	Status
Peking University First Hospital	Beijing	China

More Peking University First Hospital trials in China

Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible Lesions Recruiting

Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients Recruiting

Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019 Starting soon

Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery Starting soon

Targeted Temperature Management on Delayed Neurocognitive Recovery in Older Patients After Major Cancer Surgery Starting soon

Other trials for the same condition

A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06969703 on ClinicalTrials.gov ↗ ← All trials in China